Examples: ICD M32, ICD R6521, ICD 8210, ICD 1970

Z5111 - ICD 10 Diagnosis Code - Encounter for antineoplastic chemotherapy - Market Size, Prevalence, Incidence, Quality Outcomes, Top Hospitals & Physicians

Want to know more about Dexur's Capabilities? Get In Touch

Key Statistics Related to Z5111 - Encounter for antineoplastic chemotherapy

Data with Symbol is only for Dexur Customers. Get in touch with us to know more.

*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.

Z5111 - Encounter for antineoplastic chemotherapy - as a primary diagnosis code Z5111 - Encounter for antineoplastic chemotherapy - as a primary or secondary diagnosis code
OUTCOMES
Avg. LOS 6.42
Readmission Rate (%) 61.26
Unplanned Readmission Rate (%) 13.24
Mortality Rate (%)
SNF Discharge Rate (%)
Home Discharge Rate (%)
PAYMENTS AND CHARGES
Total Medicare Payments
Payment Per Day
Payment Per Hospitalization
Total Medicare Charges
Avg. Charges
MARKET SIZING & INCIDENCE RATES
Total National Projected Hospitalizations - Annualized (Present on Admission - All)
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All)
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes)
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes)
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y)
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y)
Total Medicare Hospitalizations after Exclusion

Table of Contents

No Quality Metrics
Top DRGs Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary diagnosis code
Top Hospitals Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary diagnosis code
Top Operating Physicians Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary diagnosis code
Top Attending Physicians Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary diagnosis code
Top DRGs Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary or secondary diagnosis code
Top Hospitals Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary or secondary diagnosis code
Top Operating Physicians Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary or secondary diagnosis code
Top Attending Physicians Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary or secondary diagnosis code
Machine Learning Identified Top 50 Most Common Comorbid Conditions Associated With Z5111 - Encounter for antineoplastic chemotherapy

Top DRGs Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary diagnosis code

  |  Back to Top

Top 1 to 5 DRGs - Oct 2015 to Sep 2018

*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.

DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 837: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 838: CHEMOTHERPY WITH ACUTE LEUKEMIA AS SDX WITH COMPLICATION OR COMORBIDITY (CC) OR HIGH DOSE CHEMOTHERAPY AGENT DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC)
Total Hospitalizations at DRG 45,065
Total Hospitalizations with ICD Z5111 - Encounter for antineoplastic chemotherapy 44,408
DRG Share of Total Hospitalizations 0.14
% of Total ICD Z5111 - Encounter for antineoplastic chemotherapy in DRG 62.42
Avg LOS at DRG 4.03
Avg LOS with ICD Z5111 - Encounter for antineoplastic chemotherapy 4.02
Readmission Rate at DRG 66.75
Readmission Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 66.89
Unplanned Readmission Rate at DRG 10.94
Unplanned Readmission Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 10.94
Total Medicare payments at DRG $438,494,977
Total Medicare payments with ICD Z5111 - Encounter for antineoplastic chemotherapy $428,856,168
Total Medicare payment per Day at DRG $2,416
Total Medicare payment per Day with ICD Z5111 - Encounter for antineoplastic chemotherapy $2,400
Total Medicare payment per Hospitalization at DRG $9,730
Total Medicare payment per Hospitalization with ICD Z5111 - Encounter for antineoplastic chemotherapy $9,657
Total Medicare Charges at DRG $2,145,591,374
Total Medicare Charges with ICD Z5111 - Encounter for antineoplastic chemotherapy $2,096,238,627
Avg Charges at DRG $47,611
Avg Charges with ICD Z5111 - Encounter for antineoplastic chemotherapy $47,204
Mortality Rate at DRG 0.08
Mortality Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 0.08
SNF Discharge Rate at DRG 4.35
SNF Discharge Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 4.38
Home Discharge Rate at DRG 81.76
Home Discharge Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 81.65

Top 5 to 10 DRGs - Oct 2015 to Sep 2018

*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.

DRG 829: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 016: AUTOLOGOUS BONE MARROW TRANSPLANT WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 826: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT
Total Hospitalizations at DRG 5,149
Total Hospitalizations with ICD Z5111 - Encounter for antineoplastic chemotherapy 1,323
DRG Share of Total Hospitalizations 0.02
% of Total ICD Z5111 - Encounter for antineoplastic chemotherapy in DRG 1.86
Avg LOS at DRG 10.0
Avg LOS with ICD Z5111 - Encounter for antineoplastic chemotherapy 16.4
Readmission Rate at DRG 32.03
Readmission Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 53.99
Unplanned Readmission Rate at DRG 16.46
Unplanned Readmission Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 18.33
Total Medicare payments at DRG $138,052,599
Total Medicare payments with ICD Z5111 - Encounter for antineoplastic chemotherapy $49,934,217
Total Medicare payment per Day at DRG $2,682
Total Medicare payment per Day with ICD Z5111 - Encounter for antineoplastic chemotherapy $2,301
Total Medicare payment per Hospitalization at DRG $26,812
Total Medicare payment per Hospitalization with ICD Z5111 - Encounter for antineoplastic chemotherapy $37,743
Total Medicare Charges at DRG $653,072,869
Total Medicare Charges with ICD Z5111 - Encounter for antineoplastic chemotherapy $279,384,462
Avg Charges at DRG $126,835
Avg Charges with ICD Z5111 - Encounter for antineoplastic chemotherapy $211,175
Mortality Rate at DRG 5.59
Mortality Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 8.01
SNF Discharge Rate at DRG 12.02
SNF Discharge Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 8.84
Home Discharge Rate at DRG 49.37
Home Discharge Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 56.69

Top 10 to 15 DRGs - Oct 2015 to Sep 2018

*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.

DRG 827: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) DRG 004: TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITHOUT MAJOR O.R. PROCEDURE DRG 830: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE
Total Hospitalizations at DRG 4,469
Total Hospitalizations with ICD Z5111 - Encounter for antineoplastic chemotherapy 54
DRG Share of Total Hospitalizations 0.01
% of Total ICD Z5111 - Encounter for antineoplastic chemotherapy in DRG 0.08
Avg LOS at DRG 6.1
Avg LOS with ICD Z5111 - Encounter for antineoplastic chemotherapy 5.31
Readmission Rate at DRG 18.8
Readmission Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 66.04
Unplanned Readmission Rate at DRG 10.96
Unplanned Readmission Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 24.53
Total Medicare payments at DRG $78,385,486
Total Medicare payments with ICD Z5111 - Encounter for antineoplastic chemotherapy $977,017
Total Medicare payment per Day at DRG $2,876
Total Medicare payment per Day with ICD Z5111 - Encounter for antineoplastic chemotherapy $3,404
Total Medicare payment per Hospitalization at DRG $17,540
Total Medicare payment per Hospitalization with ICD Z5111 - Encounter for antineoplastic chemotherapy $18,093
Total Medicare Charges at DRG $393,997,363
Total Medicare Charges with ICD Z5111 - Encounter for antineoplastic chemotherapy $4,189,294
Avg Charges at DRG $88,162
Avg Charges with ICD Z5111 - Encounter for antineoplastic chemotherapy $77,580
Mortality Rate at DRG 0.58
Mortality Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy NA
SNF Discharge Rate at DRG 8.32
SNF Discharge Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy NA
Home Discharge Rate at DRG 63.15
Home Discharge Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 72.22

Top Hospitals Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary diagnosis code

  |  Back to Top

Hospital Name Address City State Zip Code Total Hospitalizations ( Oct 2015 to Sep 2018 )
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD HOUSTON TX 77030 2,562
MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS 1216 2ND ST SW ROCHESTER MN 55902 1,178
MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVE NEW YORK NY 10065 1,034

Top Operating Physicians Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary diagnosis code

  |  Back to Top

Physician Name Address City State Zip Code Total Hospitalizations ( Oct 2015 to Sep 2018 )
Dr. VIKAS BHUSHAN 7777 FOREST LN DALLAS TX 75230 214
Dr. LORI ANN LESLIE 1515 HOLCOMBE BLVD, UNIT 463 HOUSTON TX 77030 147
Dr. NEEL KAMAL GUPTA 1959 NE PACIFIC ST SEATTLE WA 98195 139

Top Attending Physicians Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary diagnosis code

  |  Back to Top

Physician Name Address City State Zip Code Total Hospitalizations ( Oct 2015 to Sep 2018 )
Dr. VIKAS BHUSHAN 7777 FOREST LN DALLAS TX 75230 337
Dr. TAMARA LEA MUSGRAVE 172 S MAYO TRL PIKEVILLE KY 41501 195
Dr. LORI ANN LESLIE 1515 HOLCOMBE BLVD, UNIT 463 HOUSTON TX 77030 183

Top DRGs Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary or secondary diagnosis code

  |  Back to Top

Top 1 to 5 DRGs - Oct 2015 to Sep 2018

*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.

DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 837: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 838: CHEMOTHERPY WITH ACUTE LEUKEMIA AS SDX WITH COMPLICATION OR COMORBIDITY (CC) OR HIGH DOSE CHEMOTHERAPY AGENT DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC)
Total Hospitalizations at DRG 45,065
Total Hospitalizations with ICD Z5111 - Encounter for antineoplastic chemotherapy 44,611
DRG Share of Total Hospitalizations 0.14
% of Total ICD Z5111 - Encounter for antineoplastic chemotherapy in DRG 56.07
Avg LOS at DRG 4.03
Avg LOS with ICD Z5111 - Encounter for antineoplastic chemotherapy 4.03
Readmission Rate at DRG 66.75
Readmission Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 66.92
Unplanned Readmission Rate at DRG 10.94
Unplanned Readmission Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 10.94
Total Medicare payments at DRG $438,494,977
Total Medicare payments with ICD Z5111 - Encounter for antineoplastic chemotherapy $431,956,398
Total Medicare payment per Day at DRG $2,416
Total Medicare payment per Day with ICD Z5111 - Encounter for antineoplastic chemotherapy $2,404
Total Medicare payment per Hospitalization at DRG $9,730
Total Medicare payment per Hospitalization with ICD Z5111 - Encounter for antineoplastic chemotherapy $9,683
Total Medicare Charges at DRG $2,145,591,374
Total Medicare Charges with ICD Z5111 - Encounter for antineoplastic chemotherapy $2,110,595,627
Avg Charges at DRG $47,611
Avg Charges with ICD Z5111 - Encounter for antineoplastic chemotherapy $47,311
Mortality Rate at DRG 0.08
Mortality Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 0.08
SNF Discharge Rate at DRG 4.35
SNF Discharge Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 4.38
Home Discharge Rate at DRG 81.76
Home Discharge Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 81.69

Top 5 to 10 DRGs - Oct 2015 to Sep 2018

*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.

DRG 829: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 016: AUTOLOGOUS BONE MARROW TRANSPLANT WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 849: RADIOTHERAPY
Total Hospitalizations at DRG 5,149
Total Hospitalizations with ICD Z5111 - Encounter for antineoplastic chemotherapy 1,340
DRG Share of Total Hospitalizations 0.02
% of Total ICD Z5111 - Encounter for antineoplastic chemotherapy in DRG 1.68
Avg LOS at DRG 10.0
Avg LOS with ICD Z5111 - Encounter for antineoplastic chemotherapy 16.38
Readmission Rate at DRG 32.03
Readmission Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 53.91
Unplanned Readmission Rate at DRG 16.46
Unplanned Readmission Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 18.47
Total Medicare payments at DRG $138,052,599
Total Medicare payments with ICD Z5111 - Encounter for antineoplastic chemotherapy $50,682,688
Total Medicare payment per Day at DRG $2,682
Total Medicare payment per Day with ICD Z5111 - Encounter for antineoplastic chemotherapy $2,309
Total Medicare payment per Hospitalization at DRG $26,812
Total Medicare payment per Hospitalization with ICD Z5111 - Encounter for antineoplastic chemotherapy $37,823
Total Medicare Charges at DRG $653,072,869
Total Medicare Charges with ICD Z5111 - Encounter for antineoplastic chemotherapy $283,463,969
Avg Charges at DRG $126,835
Avg Charges with ICD Z5111 - Encounter for antineoplastic chemotherapy $211,540
Mortality Rate at DRG 5.59
Mortality Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 8.13
SNF Discharge Rate at DRG 12.02
SNF Discharge Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 8.81
Home Discharge Rate at DRG 49.37
Home Discharge Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 56.72

Top 10 to 15 DRGs - Oct 2015 to Sep 2018

*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.

DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC)
Total Hospitalizations at DRG 45,432
Total Hospitalizations with ICD Z5111 - Encounter for antineoplastic chemotherapy 206
DRG Share of Total Hospitalizations 0.14
% of Total ICD Z5111 - Encounter for antineoplastic chemotherapy in DRG 0.26
Avg LOS at DRG 4.42
Avg LOS with ICD Z5111 - Encounter for antineoplastic chemotherapy 4.53
Readmission Rate at DRG 30.74
Readmission Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 31.0
Unplanned Readmission Rate at DRG 18.94
Unplanned Readmission Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 19.5
Total Medicare payments at DRG $376,347,273
Total Medicare payments with ICD Z5111 - Encounter for antineoplastic chemotherapy $1,627,706
Total Medicare payment per Day at DRG $1,873
Total Medicare payment per Day with ICD Z5111 - Encounter for antineoplastic chemotherapy $1,745
Total Medicare payment per Hospitalization at DRG $8,284
Total Medicare payment per Hospitalization with ICD Z5111 - Encounter for antineoplastic chemotherapy $7,901
Total Medicare Charges at DRG $1,794,383,177
Total Medicare Charges with ICD Z5111 - Encounter for antineoplastic chemotherapy $9,380,999
Avg Charges at DRG $39,496
Avg Charges with ICD Z5111 - Encounter for antineoplastic chemotherapy $45,539
Mortality Rate at DRG 0.61
Mortality Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy NA
SNF Discharge Rate at DRG 7.48
SNF Discharge Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy NA
Home Discharge Rate at DRG 67.79
Home Discharge Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 79.61

Top 15 to 20 DRGs - Oct 2015 to Sep 2018

*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.

DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC)
Total Hospitalizations at DRG 443,386
Total Hospitalizations with ICD Z5111 - Encounter for antineoplastic chemotherapy 144
DRG Share of Total Hospitalizations 1.35
% of Total ICD Z5111 - Encounter for antineoplastic chemotherapy in DRG 0.18
Avg LOS at DRG 5.27
Avg LOS with ICD Z5111 - Encounter for antineoplastic chemotherapy 5.89
Readmission Rate at DRG 21.6
Readmission Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 28.46
Unplanned Readmission Rate at DRG 15.91
Unplanned Readmission Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 18.46
Total Medicare payments at DRG $3,812,834,208
Total Medicare payments with ICD Z5111 - Encounter for antineoplastic chemotherapy $1,295,170
Total Medicare payment per Day at DRG $1,632
Total Medicare payment per Day with ICD Z5111 - Encounter for antineoplastic chemotherapy $1,527
Total Medicare payment per Hospitalization at DRG $8,599
Total Medicare payment per Hospitalization with ICD Z5111 - Encounter for antineoplastic chemotherapy $8,994
Total Medicare Charges at DRG $18,110,468,211
Total Medicare Charges with ICD Z5111 - Encounter for antineoplastic chemotherapy $7,304,169
Avg Charges at DRG $40,846
Avg Charges with ICD Z5111 - Encounter for antineoplastic chemotherapy $50,723
Mortality Rate at DRG 3.59
Mortality Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy NA
SNF Discharge Rate at DRG 22.57
SNF Discharge Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 11.81
Home Discharge Rate at DRG 40.95
Home Discharge Rate with ICD Z5111 - Encounter for antineoplastic chemotherapy 52.78

Top Hospitals Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary or secondary diagnosis code

  |  Back to Top

Hospital Name Address City State Zip Code Total Hospitalizations ( Oct 2015 to Sep 2018 )
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD HOUSTON TX 77030 2,735
MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS 1216 2ND ST SW ROCHESTER MN 55902 1,209
MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVE NEW YORK NY 10065 1,071

Top Operating Physicians Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary or secondary diagnosis code

  |  Back to Top

Physician Name Address City State Zip Code Total Hospitalizations ( Oct 2015 to Sep 2018 )
Dr. VIKAS BHUSHAN 7777 FOREST LN DALLAS TX 75230 214
Dr. LORI ANN LESLIE 1515 HOLCOMBE BLVD, UNIT 463 HOUSTON TX 77030 147
Dr. NEEL KAMAL GUPTA 1959 NE PACIFIC ST SEATTLE WA 98195 139

Top Attending Physicians Associated With Z5111 - Encounter for antineoplastic chemotherapy - as a primary or secondary diagnosis code

  |  Back to Top

Physician Name Address City State Zip Code Total Hospitalizations ( Oct 2015 to Sep 2018 )
Dr. VIKAS BHUSHAN 7777 FOREST LN DALLAS TX 75230 340
Dr. TAMARA LEA MUSGRAVE 172 S MAYO TRL PIKEVILLE KY 41501 195
Dr. LORI ANN LESLIE 1515 HOLCOMBE BLVD, UNIT 463 HOUSTON TX 77030 183

AI Identified Top 50 Most Common Comorbid Conditions Associated With Z5111 - Encounter for antineoplastic chemotherapy   |  Back to Top

No ICD Diagnosis Code Description
1 A4181 Sepsis due to Enterococcus
2 Z8349 Family history of other endocrine, nutritional and metabolic diseases
3 C729 Malignant neoplasm of central nervous system, unspecified
4 C562 Malignant neoplasm of left ovary
5 Z841 Family history of disorders of kidney and ureter
6 C8378 Burkitt lymphoma, lymph nodes of multiple sites
7 C495 Malignant neoplasm of connective and soft tissue of pelvis
8 C6291 Malignant neoplasm of right testis, unspecified whether descended or undescended
9 C4021 Malignant neoplasm of long bones of right lower limb
10 C6292 Malignant neoplasm of left testis, unspecified whether descended or undescended
11 C6290 Malignant neoplasm of unspecified testis, unspecified whether descended or undescended
12 R030 Elevated blood-pressure reading, without diagnosis of hypertension
13 E232 Diabetes insipidus
14 C8373 Burkitt lymphoma, intra-abdominal lymph nodes
15 C8511 Unspecified B-cell lymphoma, lymph nodes of head, face, and neck
16 C419 Malignant neoplasm of bone and articular cartilage, unspecified
17 B954 Other streptococcus as the cause of diseases classified elsewhere
18 C609 Malignant neoplasm of penis, unspecified
19 G4709 Other insomnia
20 C180 Malignant neoplasm of cecum
21 K5289 Other specified noninfective gastroenteritis and colitis
22 C561 Malignant neoplasm of right ovary
23 D47Z1 Post-transplant lymphoproliferative disorder (PTLD)
24 C493 Malignant neoplasm of connective and soft tissue of thorax
25 C499 Malignant neoplasm of connective and soft tissue, unspecified
26 C8371 Burkitt lymphoma, lymph nodes of head, face, and neck
27 C8449 Peripheral T-cell lymphoma, not classified, extranodal and solid organ sites
28 C9240 Acute promyelocytic leukemia, not having achieved remission
29 C182 Malignant neoplasm of ascending colon
30 M3500 Sicca syndrome, unspecified
31 Z932 Ileostomy status
32 C8190 Hodgkin lymphoma, unspecified, unspecified site
33 C9001 Multiple myeloma in remission
34 Z8261 Family history of arthritis
35 A408 Other streptococcal sepsis
36 K047 Periapical abscess without sinus
37 C9140 Hairy cell leukemia not having achieved remission
38 C8598 Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites
39 C9500 Acute leukemia of unspecified cell type not having achieved remission
40 C8313 Mantle cell lymphoma, intra-abdominal lymph nodes
41 J479 Bronchiectasis, uncomplicated
42 I69398 Other sequelae of cerebral infarction
43 Z85818 Personal history of malignant neoplasm of other sites of lip, oral cavity, and pharynx
44 C92Z0 Other myeloid leukemia not having achieved remission
45 C187 Malignant neoplasm of sigmoid colon
46 C865 Angioimmunoblastic T-cell lymphoma
47 C569 Malignant neoplasm of unspecified ovary
48 C8591 Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck
49 R180 Malignant ascites
50 C9201 Acute myeloblastic leukemia, in remission